However, disrupting the permanent colonisation of Fn in the host and effectively inhibiting NLRP3 expression and MDSCs enrichment are of great significance for actively and effectively improving the clinical efficacy of CDDP and prolonging the survival of patients with ESCC. Here, NLRP3 is linked to esophageal squamous cell carcinoma.